President Vladimir Putin says NSA leaker Edward Snowden may stay in Russia, if he wants to, but only if he stops activities aimed against the United States.
“There is one condition if he wants to remain here: he must stop his work aimed at damaging our American partners. As odd as it may sound from me,” Putin told a media conference in Moscow.
In Putin’s opinion, Snowden considers himself “a fighter for human rights” and it seems unlikely that he is going to stop leaking American secret data.
However, Russia is not going to extradite Snowden, the president underlined.
“Russia has never extradited anyone and is not going to do so. Same as no one has ever been extradited to Russia,” Putin stated.
“At best,” he noted, Russia exchanged its foreign intelligence employees detained abroad for “those who were detained, arrested and sentenced by a court in the Russian Federation.”
Snowden “is not a Russian agent”, the president said, repeating that Russian intelligence services were not working with the fugitive American.
He said Snowden should choose his final destination and go there. Putin added that he has no idea when that is going to happen.
“If I knew, I would tell you now,” he told the media conference after the Forum of Gas Exporting Countries.
Putin and his US counterpart Barrack Obama instructed their nations’ security services – Russia’s FSB and America’s FBI respectively – to resolve the situation around the Snowden case, Nikolay Patrushev, the secretary of the Russian Security Council said earlier on Monday.
The former CIA employee Snowden, who is behind the biggest leak in the NSA, has been stuck in the transit zone of Moscow’s Sheremetyevo Airport for over a week now, after he arrived in the Russian capital from Hong Kong.
The US annulled the whistleblower’s American passport and he presently has no other documents with which he can travel.
he American states of Washington and Colorado made international news last November, when voters from both states passed initiatives to legalize the use of marijuana for recreational use. Voters had previously voted for laws protecting cannabis use for qualified medical patients, but the support for all-out legalization seems to be fading amongst figures in the medical community.
In a surprising turn of events, many medical marijuana patients have spoken out publicly against the legalization of cannabis for recreational use. Many of the same people who spent decades crusading for legalization have now turned against it. Citing concern with the new law’s taxes and regulations, groups have popped up to attempt to protect Washington’s medical marijuana law, and keep it completely separate from the state’s new law. Their opponents say that medical patients have a curb on a black market, and a few are profiting from loopholes in the medical cannabis laws.
Many advocates for cannabis legalization have fought for years to see it become a reality. When Washington legalized marijuana for medical use, it was seen by most in pro-cannabis camps as a major victory. Since then, numerous medical marijuana storefronts have sprung up all over the state, calling themselves “collectives” or “co-ops”. While the dispensaries are explicitly prohibited in the language of the state’s medical marijuana law, most of these storefronts operate in the same fashion. It has become a lucrative market for co-op owners, as well as farmers and managers of collective gardens, seeking to exchange their crops for donations instead of selling it outright.
In Washington state, legalization went into effect on December 6th, after Initiative 502 passed by a popular vote a month before. Anyone over the age of 21 is now allowed to carry up to one ounce of dried cannabis in the state. Over the course of a year, the Washington State Liquor Control Board was charged with the task of drafting the rules for a retail system, in which taxes up to 25 percent were to be levied. Also, growers, retailers, and distributors would need be licensed by the state to lawfully carry out their business activities.
And it’s exactly these taxes and licenses that have the medical marijuana crowd up in arms over the passing of Initiative 502 (I-520).
Pat Hynes, who is a part-owner of Professional Patient Co-op located in Seattle’s Fremont neighbourhood, said his concerns mostly lie with the needs of medical patients. “I have a lot of people coming into our shop who are sick. They are in pain. And they need medicine. Many can’t afford to pay for their medication as it is. How are they supposed to be able to afford it when an extra 25-50% tax is put on top of it?” he said. Hynes regularly gives medicine to lower-income patients for free, citing his concern for the well-being of his patients.
Another group majorly concerned with the Liquor Board’s incoming regulations are medical marijuana growers. Many growers are concerned that big business will infiltrate their market and run them out of the game altogether. Among the corporations rumoured to be lobbying in Olympia are familiar names such as brewers AB InBev and tobacco giants Phillip Morris.
Since the passing of I-502, many growers have come public with their crops after growing as outlaws for years. Many have been perfecting their techniques for decades, leading to product with as high of quality as anywhere in the world. With increased regulation by the state, many fear the level of quality and potency achieved by these small-time growers will be eradicated as giant marijuana farms used to feed state-owned storefronts could become the new reality. If that system were to become the new norm, priorities could shift from quality to quantity.
Nine more cases of deadly fungal meningitis were reported from an outbreak tied to steroid medications shipped by a Massachusetts company, bringing the national total to 377 cases, U.S. health officials said on Thursday.
No new deaths were reported on Thursday and the Centers for Disease Control and Prevention said Virginia had revised down the number of deaths there to two from three, reducing the national fatality total to 28. The CDC gave no reason for the revision.
In addition to the 377 cases of meningitis, the CDC said there also were nine reported cases of infections after a potentially contaminated steroid was injected into a joint such as a knee, hip, shoulder or elbow, bringing the total number of infections nationwide to 386.
The steroid was supplied by New England Compounding Center of Massachusetts, which faces multiple investigations. Health authorities have said its facility near Boston failed to make medications in sterile conditions. A fungus was found in some of the vials of steroid produced by the company and bacteria was found in other drugs from the facility.
A sister company of NECC, Ameridose, on Wednesday recalled all of its products in a move to cooperate with authorities. The recall could lead to shortages of some drugs
the Presidant is chief executive officer of the corperation usa um bull shit